Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cells for ovarian failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Insufficiency

Drugs mentioned

• Cultured allogeneic umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Ovarian Failure | Phase 1 | Status: WITHDRAWN